Time to Resolution of Iodine‐123 Metaiodobenzylguanidine (123I‐MIBG) Avidity and Local Control Outcomes for High‐risk Neuroblastoma Following Radiation Therapy
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY(2023)
摘要
123I‐MIBG scan is used in neuroblastoma (NB) to monitor treatment response. Time to resolution of 123I‐MIBG avidity after radiation therapy (RT) is unknown. We sought to determine time to resolution of 123I‐MIBG avidity after RT and local failure (LF) rate.
更多查看译文
关键词
Neuroblastoma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要